Filter
647
Filtered Results: 647
Text search:
laboratory
biosafety
Featured
Recommendations
103
New Publications
155
Language
Document type
No document type
321
Guidelines
153
Studies & Reports
68
Manuals
53
Strategic & Response Plan
29
Training Material
8
Fact sheets
6
Situation Updates
5
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
India
42
Sierra Leone
25
Nigeria
20
Latin America and the Carribbean
19
Western and Central Europe
18
Global
17
Africa
16
Liberia
15
Kenya
13
Rwanda
13
Uganda
13
Ghana
12
Eastern Europe
11
Brazil
11
West and Central Africa
10
Ethiopia
10
East and Southern Africa
8
Zambia
8
Ukraine
7
Guinea
7
Mozambique
7
Tanzania
7
Congo, Democratic Republic of
7
Bangladesh
7
Nepal
6
Philippines
6
Middle East and North Africa
6
South–East Asia Region
6
South Africa
6
Angola
6
Syria
5
Malawi
5
Russia
5
Pakistan
5
Burkina Faso
4
Eastern Europe and Central Asia
4
Spain
4
Namibia
4
Tajikistan
3
Guinea-Bissau
3
Western Pacific Region
3
Myanmar / Burma
3
Colombia
2
Cameroon
2
Senegal
2
Afghanistan
2
USA
2
Cambodia
2
Germany
2
Saudi Arabia
2
Lebanon
2
Sudan
2
Georgia
2
North Macedonia
1
Togo
1
China
1
Chile
1
Iran
1
Albania
1
Laos
1
Burundi
1
Peru
1
Zimbabwe
1
Morocco
1
Bulgaria
1
Mauritania
1
Italy
1
Asia
1
Venezuela
1
Hungary
1
Jordan
1
Paraguay
1
North America
1
Gabon
1
Mauritius
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Vietnam
1
Moldova
1
Sri Lanka
1
Yemen
1
Romania
1
Slovakia
1
Greece
1
Central African Republic
1
Poland
1
Chad
1
Bhutan
1
South Sudan
1
Indonesia
1
Iraq
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
231
Pharmacy & Technologies
56
Clinical Guidelines
54
Key Resources
30
Public Health
24
Women & Child Health
7
Capacity Building
2
Toolboxes
COVID-19
138
TB
113
Rapid Response
86
Ebola & Marburg
69
AMR
39
NTDs
20
HIV
19
Planetary Health
11
Zika
11
Pharmacy
9
Conflict
9
Polio
8
Caregiver
7
Specific Hazards
4
Natural Hazards
4
Cholera
3
Health Financing Toolbox
3
Mental Health
2
Malaria
2
Refugee
1
Global Health Education
1
The WHO Cholera Rapid Diagnostic Test (RDT) Target Product Profile outlines the key requirements for developing improved cholera RDTs. It highlights the need for fast, accurate, and easy-to-use tests for early outbreak detection in resource-limited settings. The document sets desired and acceptable ...
The main objective of this mission was to assess the level of preparedness of Guinea-Bissau in respect of the WHO consolidated checklist. The checklist helps countries to assess and test their level of readiness it is being used to identify concrete action to be taken and where countries will requir...
Hepatitis aguda de etiología desconocida en niños: Orientaciones provisionales para los laboratorios
Este documento ofrece una orientación provisional a los países sobre las consideraciones y estrategias de análisis para los casos sospechosos de hepatitis aguda grave de etiología desconocida en niños. Está dirigido principalmente a las partes interesadas en el ámbito clínico, programático,...
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10...
The following protocol has been designed to investigate the extent of infection, as determined by seropositivity in the general population, in any country in which COVID-19 virus infection has been reported. Each country may need to tailor some aspects of this protocol to align with public health, l...
The immediate objective of the country visit to Cameroon was to ensure that the country is as operationally ready as possible to effectively and safely detect, investigate and report potential Ebola virus disease cases and to mount an effective response that will prevent a larger outbreak. After te...
The preparedness strengthening team deployed to Ghana focused on specific objectives in order to assist the country in becoming as operationally prepared as possible to detect, investigate and report potential EVD cases effectively and safely and to mount an effective response to prevent a larger o...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
This document aims to provide global guidance on poliomyelitis (polio) surveillance in the context of the COVID-19 pandemic. It comes as a technical complement to Polio eradication programme continuity, Immunization in the context of COVID-19 pandemic frequently asked questions, and is aligned with ...
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
30 April 2020
| COVID-19: Essential health services
The BRM ATP is an advanced course in biorisk management. The 10-day train-the-trainer course introduces the concept of biorisk management, which combines risk assessment, risk mitigation, and performance systems (AMP). The course also includes a cutting-edge training component based on the latest sc...
Instruction for Use
second edition
Interim Guidance 31 march 2020
WHO has established a shipment mechanism to expedite and cover the costs of the shipment of clinical samples from patients with suspected COVID-19 from the country of collection to one of the WHO reference laboratories providing confirmatory molecular testing for COVI...
orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommandations relatives aux stratégies nationales de dépistage et à l'utilisation de la PCR et des tests an...
